ecancermedicalscience

Special Issue

Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment

5 Sep 2018
Anna Louise Pouncey, Alasdair James Scott, James Leslie Alexander, Julian Marchesi, James Kinross

The gut microbiota exists in a dynamic balance between symbiosis and pathogenesis and can influence almost any aspect of host physiology. Growing evidence suggests that the gut microbiota not only plays a key role in carcinogenesis but also influences the efficacy and toxicity of anticancer therapy. The microbiota modulates the host response to chemotherapy via numerous mechanisms, including immunomodulation, xenometabolism and alteration of community structure. Furthermore, exploitation of the microbiota offers opportunities for the personalisation of chemotherapeutic regimens and the development of novel therapies. In this article, we explore the host-chemotherapeutic microbiota axis, from basic science to clinical research, and describe how it may change the face of cancer treatment.

Article metrics: 8213 views
1043
7170

Related Articles

Nieves Martínez Lago, María Vieito Villar, Rafael Varela Ponte, Ihab Abdulkader Nallib, Juan José Carrera Alvarez, José Ramón Antúnez López, Rafael López López, María Elena Padin Iruegas
Muhammad Shahid Iqbal, Joseph Carlow, Fiona McDonald, Philip Atherton, Helen Turnbull, Sandeep Singhal, Timothy Simmons, Paula Mulvenna, Josef Kovarik, Rhona McMenemin, Jill Gardiner, Alastair Greystoke
Tiago Cordeiro Felismino, Victor Hugo Fonseca de Jesus, Bruno Cezar de Mendonça Uchóa Junior, Francisca Giselle Rocha Moura, Rachel P Riechelmann, Samuel Aguiar Junior, Celso Abdon Lopes de Mello